INS and type 2 diabetes mellitus: Comparison of insulin degludec/insulin aspart and biphasic insulin aspart 30 in uncontrolled insulin-treated type 2 diabetes: a phase 3 a, randomized, treat-to-target trial BOOST: Intensity Premix I Investigators.